Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Infection with antibiotic-resistant bacteria, such as vancomycin-resistant Enterococcus (VRE), is a dangerous and costly complication of broad-spectrum antibiotic therapy. How antibiotic-mediated elimination of commensal bacteria promotes infection by antibiotic-resistant bacteria is a fertile area for speculation with few defined mechanisms. Here we demonstrate that antibiotic treatment of mice notably downregulates intestinal expression of RegIIIgamma (also known as Reg3g), a secreted C-type lectin that kills Gram-positive bacteria, including VRE. Downregulation of RegIIIgamma markedly decreases in vivo killing of VRE in the intestine of antibiotic-treated mice. Stimulation of intestinal Toll-like receptor 4 by oral administration of lipopolysaccharide re-induces RegIIIgamma, thereby boosting innate immune resistance of antibiotic-treated mice against VRE. Compromised mucosal innate immune defence, as induced by broad-spectrum antibiotic therapy, can be corrected by selectively stimulating mucosal epithelial Toll-like receptors, providing a potential therapeutic approach to reduce colonization and infection by antibiotic-resistant microbes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Colonization resistance takes place through direct (not requiring host involvement) or indirect mechanisms (ultimately mediated by the host response, as mentioned above for the modulation of AMPs) [18, 19].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Systemic administration of TLR-5 agonist flagellin, or oral administration of TLR-4 agonist LPS, were shown to reinstate resistance to VRE or C. difficile in mice previously treated with antibiotics, through restoration of RegIII-γ production [18-20].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“a defect that can be reverted by oral administration of LPS [18]”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
In the citing paper
“even short-term antibiotic treatment impairs its expression, rendering mice susceptible to vancomycin-resistant enterococcus (VRE) infection”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Symbiotic bacteria direct expression of an intestinal bactericidal lectin
Cash, H. L., Whitham, C. V., Behrendt, C. L., & Hooper, L. V. (2006) · Science · doi:10.1126/science.1127119 · Cited by 1,432
Kelly, C. P., Pothoulakis, C., & LaMont, J. T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300406 · Cited by 1,321
Epithelial NEMO links innate immunity to chronic intestinal inflammation
Nenci, A., Becker, C., Wullaert, A., Gareus, R., van Loo, G., Danese, S., Huth, M., Nikolaev, A., Neufert, C., Madison, B., et al. (2007) · Nature · doi:10.1038/nature05698 · Cited by 1,077
Nosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., Gaynes, R. P., & System, N. N. I. S. (2000) · Infection Control & Hospital Epidemiology · doi:10.1086/501795 · Cited by 1,028
Angiogenins: a new class of microbicidal proteins involved in innate immunity
Hooper, L. V., Stappenbeck, T. S., Hong, C. V., & Gordon, J. I. (2003) · Nature Immunology · doi:10.1038/ni888 · Cited by 929
Vancomycin-Resistant Enterococcal Infections
Murray, B. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421007 · Cited by 890
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Kanzler, H., Barrat, F. J., Hessel, E. M., & Coffman, R. L. (2007) · Nature Medicine · doi:10.1038/nm1589 · Cited by 869
Cario, E., Rosenberg, I. M., Brandwein, S. L., Beck, P. L., Reinecker, H.-C., & Podolsky, D. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.966 · Cited by 751
Donskey, C. J., Chowdhry, T. K., Hecker, M. T., Hoyen, C. K., Hanrahan, J. A., Hujer, A. M., Hutton-Thomas, R. A., Whalen, C. C., Bonomo, R. A., & Rice, L. B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432604 · Cited by 689
Cited by
Items 501–600 of 630
Role of Gut Microbiota in Immune Homeostasis
Tungland, B. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814649-1.00004-1 · Cited by 8
Nanoparticles for Biofilm Control
Ranjit, P., Aerupula, M., Shaik, F., & Reddy, K. V. (2021) · Environmental and microbial biotechnology · doi:10.1007/978-981-15-9916-3_9 · Cited by 5
Rahim, H., Taylor, M. R., Hirota, S. A., & Greenway, S. C. (2018) · Transplant Research and Risk Management · doi:10.2147/trrm.s143063 · Cited by 6
“Brandl et al 84 also demonstrated that dysbiosis induced by oral administration of vancomycin can modulate T reg phenotype to increase the likelihood of proinflammatory alloreactive T-cell responses, which demonstrates additional unintended complications of posttransplant antibiotics.”
Does the change on gastrointestinal tract microbiome affects host?
Beirão, E. M., Padovan, A. C. B., Furtado, J. J. D., Colombo, A. L., & Medeiros, E. A. (2014) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2014.04.002 · Cited by 9
The Impact of Gut Microbiota in Human Health and Diseases: Implication for Therapeutic Potential
Ha, E.-M. (2011) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2011.19.2.155 · Cited by 8
Upregulation of Superoxide Dismutase Activity in the Intestinal Tract Mucosa of Germ-Free Mice
DOBASHI, Y., Yoshimura, H., ATARASHI, E., Takahashi, K., Tohei, A., & Amao, H. (2012) · Journal of Veterinary Medical Science · doi:10.1292/jvms.12-0248 · Cited by 5
“Some genes coding for antimicrobial factors have been demonstrated to be induced by microbial stimuli in mono-associating or conventionalizing GF mice, by comparing GF and CV mice or by microbiota depleted mice [4, 29].”
BackgroundGut Microbiology: Fitting into the Intestinal Neighbourhood
Willing, B. P., & Finlay, B. B. (2009) · Current Biology · doi:10.1016/j.cub.2009.04.025 · Cited by 6
Geraldes, C., Araújo, C., Pinheiro, A. C., Afonso, M., Carapeto, S., Verdial, C., Cunha, E. S., Abreu, R., Tavares, L. M., Chambel, L., et al. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1458069 · Cited by 6
Shift in risk factors for mortality by period of the bloodstream infection timeline
Choi, M. H., Kim, D., Kim, J., Song, Y. G., & Jeong, S. H. (2023) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2023.11.008 · Cited by 4
Tjhin, V. T., Oda, M., Yamashita, M., Iwaki, T., Fujita, Y., Wakame, K., Inagawa, H., & Soma, G. (2024) · Scientific Reports · doi:10.1038/s41598-024-66081-2 · Cited by 4
Macrophages and Kupffer Cells in Drug-Induced Liver Injury
Barnes, M. A., Dixon, L. J., Liu, Z., Tang, H., & Nagy, L. E. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-387817-5.00009-1 · Cited by 4
L’Entérocoque résistant à la vancomycine (ERV)
Lesens, O. (2009) · Néphrologie & Thérapeutique · doi:10.1016/s1769-7255(09)74556-0 · Cited by 4
“L’administration de lipopolysaccharides (présents chez les bacilles Gram négatifs) ré-augmente l’expression de Reg3g et rétablit l’immunité innée contre l’ERV [27].”
The Gut Microbiota: Ecology and Function
Willing, B. P., & Jansson, J. K. (2014) · ASM Press eBooks · doi:10.1128/9781555816865.ch3 · Cited by 4
“In a separate study, Brandl et al. (2008) reported that the normal microbiota seemingly inadvertently prevented infection by enterococci by causing the host to secrete the antimicrobial peptide, RegIIIγ.”
BackgroundLinking membrane trafficking and intestinal homeostasis
Moresco, E. M. Y., & Brandl, K. (2013) · Tissue Barriers · doi:10.4161/tisb.23119 · Cited by 4
Self-citationEmergence and management of drug-resistant enterococcal infections
Miller, W. R., Murray, B. E., & Arias, C. A. (2013) · Microbial Drug Resistance · doi:10.2217/ebo.12.357 · Cited by 5
Channaiah, L. H. (2009) · K-State Research Exchange (Kansas State University) · Cited by 4
Emergence of antibiotic resistance in gut microbiota and its effect on human health
Kumar, M., Sharma, A., Verma, A., & Shrivastava, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91313-3.00002-7 · Cited by 4
Nabavi, S. P. T., Chamanara, M., Moghaddam, A. D., Ghorbani, M., Heidari, R., Khomartash, M. S., Behroozi, J., Khiavi, F. M., & Shakerimoghaddam, A. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-10100-0 · Cited by 3
“Antibiotics reduce intestinal gram-negative bacteria, lead to a decrease in the expression of the antimicrobial peptide Reg3γ, and facilitate the growth of E. faecium [41].”
BackgroundMiki, T., Yamaguchi, H., Kobayashi, M., Ito, M., Haneda, T., Okada, N., & Kim, Y. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013665 · Cited by 3
The role of the gut microbiome in multidrug-resistant organism colonization and infection
Merrick, B., Cooper, R., Davido, B., & Goldenberg, S. D. (2026) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2026.01.009 · Cited by 3
Mori, D., & Goto, Y. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-026-06219-9 · Cited by 4
“For example, TLR2/4 signaling mediates MyD88-induced epithelial growth and the production of antimicrobial molecules such as RegIIIβ/γ [ 5, 15].”
Götz, L., Ansafi, T., Gerken, M., Klinkhammer‐Schalke, M., Fischl, A., Riemenschneider, M. J., Proescholdt, M. A., Bumes, E., Kölbl, O., Schmidt, N. O., et al. (2024) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdae170 · Cited by 3
“40 Therefore, it is conceivable that patients treated with antibiotics are more prone to infection, resulting in higher CRP levels that may be predictive for prognosis in GB patients.”
Chatrizeh, M., Tian, J., Rogers, M. B., Feturi, F. G., Wu, G. G., Firek, B., Nikonov, R., Cass, L., Sheppeck, A., Ramos-Jiménez, R. G., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.199827 · Cited by 3
“Similarly, we confirmed previous findings that ABX treatment decreases ileal REG3G expression (Figure 3F) (53).”
Microbial Regulation of Gastrointestinal Immunity in Health and Disease
Patrick, S., Ingram, R. J., Schneiders, T., & Fitzgerald, D. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-28609-9_3 · Cited by 4
Incidence of Vancomycin Resistant Enterococci Colonization in Zagazig University Pediatric ICU
Fakhr, A. E., Shokry, M., Elhewala, A., & Megahed, A. (2018) · The Egyptian Journal of Medical Microbiology · doi:10.12816/0054169 · Cited by 3
Wu, Y., Xiaolei, T., Hu, F., Zhu, T., Liu, H., Xiong, Y., Zuo, X., Xu, A., & Zhuang, X. (2022) · Immunologic Research · doi:10.1007/s12026-022-09313-9 · Cited by 3
“Antibiotic use leads to a decrease in the amount of specific commensal bacteria as well as decreases in pathogen-associated molecular patterns, such as lipopolysaccharide (LPS), lipoteichoic acid, and flagellum protein, which results in a reduced stimulation to pattern recognition receptors on the intestine and downre…”
BackgroundEarly Exposure to Gut Microbiome Reduces Hepatocellular Carcinoma Risks in Mice
Lee, Y.-M., Chang, W., Lei, F., Kor, C., Lai, H., Chen, Y., & Ma, W. (2020) · BioMed Research International · doi:10.1155/2020/9807379 · Cited by 3
“Therefore, a lack of microbial signaling might result in innate immunity deficits and change the composition of gut microbiota [13], which might potentially cause bacterial dysbiosis and gut barrier dysfunction [14].”
BackgroundVancomycin Resistant Enterococci (VRE) in equine-faecal samples
Ahmed, M. O., Clegg, P., Williams, N. J., Baptiste, K. E., & Bennett, M. (2011) · International Conference on Antimicrobial Research (ICAR) · doi:10.1142/9789814354868_0070 · Cited by 3
ALTERATION OF THE GUT MICROBIOME FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A REVIEW
Al-Amrah, H., Saadah, O. I., Mosli, M. H., Edris, S., Al-Hindi, R. R., & Bahieldin, A. (2020) · Applied Ecology and Environmental Research · doi:10.15666/aeer/1805_73797392 · Cited by 3
“For instance, lipopolysaccharides and flagellin derived from the gut microbiota enhance the expression of antimicrobial peptide and RegIIIγ, from epithelial cells by stimulating Toll-like receptor 4+ stromal cells and TLR5+CD103+ dendritic cells (Brandl et al., 2008; Kinnebrew et al., 2010).”
BackgroundMultidrug-Resistant Organisms: Pre-transplant Evaluation and Management
Nellore, A., & Lee, R. A. (2021) · Springer eBooks · doi:10.1007/978-3-030-25869-6_8 · Cited by 3
Population Dynamics of Patients with Bacterial Resistance in Hospital Environment
Qu, L., Pan, Q., Gao, X., & He, M. (2016) · Computational and Mathematical Methods in Medicine · doi:10.1155/2016/1826029 · Cited by 3
Hu, Y., Li, Y. C., Zhang, Q., Tan, Q., Liu, H., Yang, Y., Jin, C., Zhang, W., Jia, J., & Wang, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1779550 · Cited by 2
Antimicrobial Agents Induced Microbiome Dysbiosis Its Impact on Immune System and Metabolic Health
Anuradha, K. T., Sarada, J., Aparna, Y., & Anju, S. (2023) · Springer eBooks · doi:10.1007/978-981-99-5114-7_5 · Cited by 2
Mei, L.-N., Wang, Z.-J., Duan, Y., Shen, J.-S., Ye, H.-B., Zhu, Y.-Y., & Luo, X.-D. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119737 · Cited by 2
Kong, M., Sun, H., Zhao, G., Chen, Z., Qi, J., Liu, J., & Zhang, Q. (2024) · Aquaculture Reports · doi:10.1016/j.aqrep.2024.102028 · Cited by 2
Honda, K., Atarashi, K., & Nishio, J. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0998-4_6 · Cited by 2
“vancomycin-resistant Enterococcus (VRE) [ 27, 28 ] .”
Shaping Intestinal Bacterial Community by TLR and NLR Signaling
Kobayashi, K. S. (2013) · World review of nutrition and dietetics · doi:10.1159/000346493 · Cited by 2
Ouwehand, A. C., & Tennilä, J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802189-7.00018-6 · Cited by 3
REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY Microbes in Gastrointestinal Health and Disease
Neish, A. S. (2009) · Cited by 2
Ardura, M. I., & Koh, A. Y. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00097-9 · Cited by 2
Tackling the Antibiotic Resistance: The “Gut” Feeling
Misra, R., Virmani, R., Dhakan, D. B., & Maji, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-48683-3_14 · Cited by 2
El ataque de las bacterias: cómo prevenirlo sin morir en el intento.
Pinilla, G., Molina, L. M., Jeannette Navarrete, O., & Arévalo, P. (2012) · Nova · doi:10.22490/24629448.1012 · Cited by 3
“La ausencia de esta estructura causa la destrucción del microorganismo al permitir el aumento considerable de la osmoralidad del citoplasma bacteriano (28,34,35).”
BackgroundThe Gut Microbiota, Probiotics and Infectious Disease
Gahan, C. G. M., O’Sullivan, G. C., & Collins, J. K. (2011) · Springer eBooks · doi:10.1007/978-94-007-0386-5_5 · Cited by 2
“This effect can be reversed through oral administration of lipopolysaccharide (the ligand for TLR4) which re-induces Reg3g and reinstates local resistance to VRE ( Brandl et al. 2008 ).”
BackgroundMa, M. (2019) · UA Campus Repository (The University of Arizona) · Cited by 2
Exploring the human microbiome: Its role and impact on overall health and disease prevention
Alotaibi, F. M., Almazam, A. A., Alenezi, S. Z., Alanazi, M. H., Lamfon, N. A., Albalawi, A. E. A., Al-Nasser, N. S., & Altheyab, S. A. (2018) · International Journal of Health Sciences · doi:10.53730/ijhs.v2ns1.15085 · Cited by 1
“It affects several other infections and inflammatory conditions: Bacteremia Risk : In patients undergoing allogeneic stem cell transplantation, the microbiota's status is associated with the risk of developing bacteremia (71-73).”
BackgroundMicrobial network assembly in bat flies with differing host specificity from North Africa
Corduneanu, A., Bendjeddou, M. L., Sándor, A. D., Mihalca, A. D., Hornok, S., Péter, Á., Khelfaoui, F., Aželytė, J., Obregón, D., Mateos‐Hernández, L., et al. (2025) · International Microbiology · doi:10.1007/s10123-025-00720-0 · Cited by 1
“…et al. 2010, 2014), short-chain fatty acids (Gantois et al. 2006), bacteriophages (Duerkop et al. 2012; Minot et al. 2011), signalling molecules (Brandl et al. 2008; Gallo and Hooper 2012), and modulation of immunity (Ichinohe et al. 2011; Naik et al. 2012; Satoh-Takayama et al. 2008) and…”
Nelson, M. E., Djorić, D., Henriksen-Hadlock, M. E., & Kristich, C. J. (2025) · mSphere · doi:10.1128/msphere.00528-25 · Cited by 1
VRE and antibiotic use in German ICUs—an ecological analysis of 15 years of surveillance data
Karras, J., Schwab, F., & Maechler, F. (2025) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaf216 · Cited by 1
Wang, B., Zhang, J., Sun, Y., Xin, W., Lai, W., Guo, T., Fu, C., Zhang, Y., Xu, H., Li, L., et al. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.01104-25 · Cited by 1
Djorić, D., Atkinson, S. N., & Kristich, C. J. (2024) · PLoS Genetics · doi:10.1371/journal.pgen.1011215 · Cited by 2
Legeay, C., Bourigault, C., Kouatchet, A., Lepelletier, D., & Zahar, J. (2015) · Réanimation · doi:10.1007/s13546-014-1011-9 · Cited by 2
“cilles et l’augmentation des bactéries appartenant au groupe des Clostridium, des Enterococcus et de la famille des Entérobactéries [36].”
BackgroundTeymournejad, O., Mobarez, A. M., Doust, R. H., & Yaslianifard, S. (2015) · International Journal of Enteric Pathogens · doi:10.17795/ijep22254 · Cited by 1
“Enterococcal infections usually occur in hospitalized patients with serious underlying illnesses such as cancer, blood disorders, kidney disease and immune deficiencies (2-5).”
BackgroundEdwards, A. T. (2012) · NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro) · Cited by 1
Gut Microbiota in Graft-versus-Host Disease
Kim, Y. (2016) · Journal of Bacteriology and Virology · doi:10.4167/jbv.2016.46.4.307 · Cited by 1
Li, Y., Li, Y., Wang, C., Gong, Z., Cao, M., Chen, M., Li, P., Qi, Y., & Xiao, C. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.04.006 · Cited by 1
Implications of Probiotics in Management of Bacterial Infections
Mukherjee, S. (2022) · Springer eBooks · doi:10.1007/978-981-19-1854-4_21 · Cited by 1
Mansoor, A., O’Neil, C. A., & Kwon, J. H. (2023) · Anaerobe · doi:10.1016/j.anaerobe.2023.102772 · Cited by 1
Suzuki, N., Purba, F. Y., Inagawa, H., Hattori, Y., & Isobe, N. (2023) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2023.110664 · Cited by 1
Liu, X., Ma, Y., Guo, J., & Wang, J. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106560 · Cited by 1
Microbiome in Defence Against Pathogens
Ramanathan, J. (2024) · Springer eBooks · doi:10.1007/978-3-031-70088-0_16 · Cited by 3
The cell wall hydrolase MltG is essential to maintain cell wall homeostasis of Enterococcus faecalis
Knotek, A. A. U., & Kristich, C. J. (2025) · Journal of Bacteriology · doi:10.1128/jb.00056-25 · Cited by 1
“establish infections (5–8).”
Martynov, V. L., & Khairdinov, A. K. (2015) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2015-3-49-62 · Cited by 1
La microbiota intestinal en el paciente crítico
Buendía, E., Sánchez, M., Cruz-Maldonado, O. A., & Castell, C. R. D. (2018) · Acta Colombiana de Cuidado Intensivo · doi:10.1016/j.acci.2018.06.010 · Cited by 3
The Role of the Bacterial Microbiota in Alcoholic and Non-alcoholic Fatty Liver Disease
Madsen, A. L., Brach, T., Kern, T., Bak, E. G., Nielsen, T., & Arumugam, M. (2018) · Springer eBooks · doi:10.1007/978-3-319-98890-0_6 · Cited by 2
Präklinische Einblicke in das Zusammenspiel von Mikrobiota und Verhalten
Schmidtner, A. K., & Neumann, I. D. (2020) · Nervenheilkunde · doi:10.1055/a-1036-4206 · Cited by 1
“[56] Brandl K, Plitas G, Mihu CN et al.”
BackgroundMultidrug-Resistant Organisms: Pre-transplant Evaluation and Management
Nellore, A., & Lee, R. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-01751-4_8-1 · Cited by 1
Heimer, S. R., Morrison, D., & Gilmore, M. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397169-2.00039-1 · Cited by 3
Bacterial Colonization and Host Immunity
Mihu, C. N., Vigil, K. J., & Adachi, J. A. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-644-3_15 · Cited by 1
“They appear to play an important role in the innate defense against L. monocytogenes and vancomycin-resistant Enterococcus [ 37 , 38].”
BackgroundSelf-citationInterplay between gut microbiota and antibiotics
Gonzalez, T. D. J. B. (2016) · doi:10.18174/394954 · Cited by 1
Flor‐Duro, A. (2021) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/166494 · Cited by 4
Organoid based models to study the role of gut microbiota metabolites in post-weaning diarrhea
van der Hee, B. (2023) · doi:10.18174/630692 · Cited by 1
de Regt, M. J. A. (2010) · Utrecht University Repository (Utrecht University) · Cited by 1
Anatomy of the Gut Barrier and Establishment of Intestinal Homeostasis
Sellge, G., Schnupf, P., & Sansonetti, P. J. (2010) · Wiley eBooks · doi:10.1002/9783527629664.ch10
ROLE OF ANTIMICROBIAL PEPTIDES IN COMBATING SHIGELLOSIS AND IN ANTIBIOTIC-ASSOCIATED DIARRHEA
Sarker, P. (2012) · Figshare · Cited by 1
Host–microbe interactions in the gut: lessons learned from models of inflammatory bowel diseases
Wine, E. (2014) · LymphoSign Journal · doi:10.14785/lpsn-2014-0014
Metagenomic Applications and the Potential for Understanding Chronic Liver Disease
Schnabl, B. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7089-3_13
Self-citationKalkandelen, S., Öztürk, G., Devecioğlu, Ö., Anak, S., Ünüvar, A., Karakaş, Z., & Ağaoğlu, L. (2013) · Çocuk Dergisi / Journal of Child · doi:10.5222/j.child.2012.117
Lactobacilli- and Staphylococcus aureus mediated modulation of immune responses in vitro
Haileselassie, Y. (2016) · DiVA (Stockholm University)
Mucosal homeostasis and inflammatory bowel disease
Reikvam, D. H. (2011) · NVA (Nasjonalt vitenarkiv)
Brandl, K., & Schnabl, B. (2016) · Wiley eBooks · doi:10.1002/9781118982907.ch22
Self-citationTowards understanding a holobiont: host-microbe interactions in Hydra
Fraune, S. (2009) · MACAU: Open Access Repository of Kiel University (University Library Kiel) · Cited by 1
Role of External and Environmental Factors in Drug Resistance Emergence: Gut Microbiota
Ryan, D., Jaiswal, S., & Suar, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-48683-3_12
Innovations in Kidney Transplant Research
Ahmad, S. B., Siskind, E. J., & Bromberg, J. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801734-0.00053-9
Pandian, J. J., & Balaji, R. V. (2018) · International Journal of Current Microbiology and Applied Sciences · doi:10.20546/ijcmas.2018.703.215
Koh, A. Y., & Pizzo, P. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2702-9.00099-4
Jurado, C. (2020) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-vy9d-ne19
In Silico Approaches for Prioritizing Drug Targets in Pathogens
Santana, M. P., Tosta, S. F. D. O., Jaiswal, A. K., Oliveira, L. D. C., Soares, S. D. C., Miyoshi, A., Alcantara, L. C. J., Azevedo, V., & Tiwari, S. (2020) · Sustainable agriculture reviews · doi:10.1007/978-3-030-53024-2_4
Strategies for inflammatory bowel disease drug research by targeting gut microbiota
Liao, Z., Ji, Q.-F., & Zhou, B. (2020) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v28.i22.1112 · Cited by 1
Engineering Symbiotic Microbiota for in Situ Delivery of Therapeutic Proteins
Debnath, A. (2018) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Uncovering the Harms of Treating Clostridioides difficile Colonization
Polage, C. R., & Turner, N. (2021) · mSphere · doi:10.1128/msphere.01296-20
“colonization, overgrowth, and infection (10).”
Rainey, P. B., & Ferguson, G. C. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718045204.793480905
Savidge, T. (2009) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1165605.628651
Söderholm, J. D. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.8671966.11278054
Ray, A., & Krishnamoorthy, N. (2010) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1165605.1505055
Saas, P., Chagué, C., & Daguindau, É. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736996728.793570749
Multidrug-Resistant Organisms: Pre-transplant Evaluation and Management
Nellore, A., & Lee, R. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-01751-4_8-2
Quigley, E. M. M. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.731115520.793569663
Articles of Significant Interest in This Issue
(2018) · Infection and Immunity · doi:10.1128/iai.00381-18
Risk Factors and Infectious Agents in Children With Cancer
Ardura, M. I., & Koh, A. Y. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75608-2.00097-5
Metadata
- Authors
- Brandl, K., Plitas, G., Mihu, C. N., Ubeda, C., Jia, T., Fleisher, M., Schnabl, B., DeMatteo, R. P., & Pamer, E. G.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- University of California San Diego (US)
- Corresponding author
- Pamer, Eric G.
- Venue
- Nature
- Published
- 2008-08-24
- Volume
- 455
- Issue
- 7214
- Pages
- 804-807
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2663337
- OpenAlex
- W2093972125
- Cited by
- 631
- References
- 28
- Citations by year
- 2026: 14 · 2025: 28 · 2024: 27 · 2023: 30 · 2022: 25 · 2021: 29 · 2020: 48 · 2019: 32 · 2018: 56 · 2017: 41 · 2016: 36 · 2015: 39 · 2014: 37 · 2013: 38 · 2012: 39
- FWCI
- 15.24
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Alexander von Humboldt-Stiftung
- National Institutes of Health (4r37ai039031-21)
- National Institute of Allergy and Infectious Diseases (AI42135, R01AI039031, R01AI080619, R37-AI039031, AI 39031, R01AI042135)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Keywords
- vancomycin-resistant enterococci, antibiotic resistance, intestinal innate immunity, RegIIIγ, C-type lectin, broad-spectrum antibiotics, TLR4, lipopolysaccharide, mucosal epithelium, commensal bacteria, antibiotic-associated infection, Gram-positive bacteria
- MeSH terms
- Pancreatitis-Associated Proteins, Animals, Immunity, Innate, Intestinal Mucosa, Intestines, Lipopolysaccharides, Proteins, Vancomycin, Signal Transduction, Down-Regulation, Enterococcus, Vancomycin Resistance, Toll-Like Receptor 4, Mice, Myeloid Differentiation Factor 88
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.